Skip to main content
Premium Trial:

Request an Annual Quote

Chad Mirkin, Huntington Willard, Lydia Villa-Komaroff

Premium

Chad Mirkin, professor of chemistry and director of the Institute of Nanotechnology & Center for Nanofabrication and Molecular Self-Assembly at Northwestern University, was named a winner of the 2002 Foresight Institute Feynman Prize, the Palo Alto, Calif.,-based organization announced last week.

The prizes are made in honor of the pioneer physicist Richard Feynman. Mirkin received an award for his experimental work in molecular machine systems, particularly in DNA. He has published work describing arrays at the 100-nanometer scale.

Huntington Willard has been named director of the Duke University Institute for Genome Sciences and Policy, the school announced last week.

Willard, 49, is currently the director and president of the Research Institute of University Hospitals of Cleveland. Willard, 49, holds a PhD in human genetics from Yale University.

Lydia Villa-Komaroff is joining the Whitehead Institute as vice president for research and chief operating officer, leaving Northwestern University where she served as vice president for research.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.